Reducing the dose of antipsychotic agents ameliorates visual hypersensitivity attack: An ideal treatment option in terms of the adverse effect

Journal of Clinical Psychopharmacology

Volumn 26, Issue 1, 2006, Pages 50-55

  Uchida, Hiroyuki ^a,b   Suzuki, Takefumi ^a   Yamazawa, Ryoko ^a,b   Tomita, Masayuki ^b   Nemoto, Takahiro ^b   Kimura, Yoshie ^b   Watanabe, Koichiro ^a,b   Imasaka, Yasushi ^b   Kashima, Haruo ^a  

^a KEIO UNIVERSITY   (Japan)

^b Ohizumi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AKATHISIA; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSKINESIA; DYSTONIA; FEMALE; GAIT DISORDER; HUMAN; HYPERSALIVATION; HYPERSENSITIVITY; INFORMATION PROCESSING; MALE; MEDICAL ASSESSMENT; MUSCLE RIGIDITY; PATIENT CARE; PERCEPTION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REDUCTION; SCHIZOPHRENIA; SCORING SYSTEM; SELF REPORT; TREMOR; VISUAL HYPERSENSITIVITY ATTACK;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MIDDLE AGED; PHOTOPHOBIA; VISUAL PERCEPTION;

EID: 31544463789     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000195384.04008.25     Document Type: Article

References (27)

1. Uchida H, Suzuki T, Watanabe K, et al. Antipsychotic-induced paroxysmal perceptual alteration. Am J Psychiatry. 2003;160:2243-2244.
2. Higuchi H, Shimizu T, Hishikawa Y. Recurrent paroxysmal episodes characterized by perceptual alteration in three schizophrenic patients on neuroleptic medication. Psychiatry Clin Neurosci. 1997;51:99-101.
3. Yamaguchi N, Nakai H. Attacks of altered perception in schizophrenics, [in Japanese] In: Uchiyama Y, ed. Psychopathology of Schizophrenia. Tokyo: Tokyo University Press; 1985;14:295-314.
4. Uchida H, Suzuki T, Tanaka KF, et al. Recurrent episodes of perceptual alteration in patients treated with antipsychotic agents. J Clin Psychopharmacol. 2003;23:496-499.
5. Uchida H, Suzuki T, Watanabe K, et al. Antipsychotics-induced hypersensitivity of visual perception. Eur Psychiatry. In press.
6. Higuchi H, Shimizu T, Hishikawa Y. Recurrent episodes of altered perceptions accompanied with or without acute dystonia in two schizophrenic patients [in Japanese]. Seishin Igaku. 1988;30:1213-1219.
7. Fukuzako H, Okazono Y, Takenouchi K, et al. Neuroleptic-induced paroxysmal perceptual alteration in a patient with manic-depressive psychosis [in Japanese]. Seishin Igaku. 1994;36:759-761.
8. Magarinos M, Carballo JJ, Garcia-Parajua P, et al. Prevalence of paroxysmal perceptual alterations with antipsychotics [Poster]. Presented at the 2005 annual meeting of American Psychiatric Association; May 21-26, 2005; Atlanta, USA.
9. Yamaguchi N. "Attack" syndrome characterized by altered perception in schizophrenics [in Japanese]. Seishinka Chiryogaku. 1986;1:117-125.
10. Guy W. ECEDU Assessment Manual for Psychopharmacology. Washington, DC: Department of Health, Education and Welfare; 1976:217-222.
11. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
12. Inada T. Evaluation and diagnosis of drug-induced extrapyramidal symptoms [in Japanese]. Tokyo: Seiwa Press; 1996.
13. Inada T, Yagi G. Current topics in neuroleptic-induced extrapyramidal symptoms in Japan. Keio J Med. 1996;45:95-99.
14. Inagaki A, Inada T, Fujii Y. Dose equivalents of psychotropic drugs [in Japanese]. Tokyo: Seiwa Press; 1999.
15. Raja M. Managing antipsychotic-induced acute and tardive dystonia. Drug Saf. 1998;19:57-72.
16. van Harten PN, Hoek HW, Kahn RS. Acute dystonia induced by drug treatment. BMJ. 1999;319:623-626.
17. Bumpass ER, Knoll JM. Emotional factors in oculogyric crisis. J Nerv Ment Dis. 1982;170:366-370.
18. Ouvrier RA. Progressive dystonia with marked diurnal fluctuation. Ann Neurol. 1978;4:412-417.
19. Mazurek MF, Rosebush PI. Circadian pattern of acute, neuroleptic-induced dystonic reactions. Am J Psychiatry. 1996;153:708-710.
20. Fahn S. Concept and classification of dystonia. Adv Neurol. 1988;50:1-8.
21. Swett C. Drug-induced dystonia. Am J Psychiatry. 1975;132:532-534.
22. Masson G, Mestre D, Blin O. Dopaminergic modulation of visual sensitivity in man. Fundam Clin Pharmacol. 1993;7:449-463.
23. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci. 1990;13:296-307.
24. Borison RL, Diamond BI. Neuropharmacology of the extrapyramidal system. J Clin Psychiatry. 1987;48:7-12.
25. Adolphs R. Neural systems for recognizing emotion. Curr Opin Neurobiol. 2002;12:169-177.
26. Davis M, Shi C. The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminals differentially involved in fear versus anxiety? Ann N Y Acad Sci. 1999;29:281-291.
27. Afifi AK. The basal ganglia: a neural network with more than motor function. Semin Pediatr Neurol. 2003;10:3-10.